1-4 of 4
Carolyn Millar
Close
Sort by
Journal Articles

Pharmacokinetics and safety of a novel recombinant human von Willebrand factor manufactured with a plasma-free method: a prospective clinical trial

Clinical Trials & Observations
Pier Mannuccio Mannucci, Christine Kempton, Carolyn Millar, Edward Romond, Amy Shapiro, Ingvild Birschmann, Margaret V. Ragni, Joan Cox Gill, Thynn Thynn Yee, Robert Klamroth, Wing-Yen Wong, Miranda Chapman, Werner Engl, Peter L. Turecek, Tobias M. Suiter, Bruce M. Ewenstein
Journal: Blood
Blood (2013) 122 (5): 648–657.
https://doi.org/10.1182/blood-2013-01-479527
Published: 2013
Includes: Supplemental data
Journal Articles

Evaluation of Primary Haemostasis in Patients Undergoing Cardiac Surgery Using a Novel Automated Microchip Flow-Chamber System (T-TAS).

Agata Anna Nowak, MSc, PhD, David NF Harris, MD, Michael Laffan, MD, Carolyn Millar, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 2171.
https://doi.org/10.1182/blood.V120.21.2171.2171
Published: 2012
Journal Articles

Flow Analysis of Von Willebrand Factor Collagen Binding Mutants

Thomas A J McKinnon, BSc, PhD, Agata Anna Nowak, MSc, PhD, Alina Hua, BSc, Carolyn Millar, MD, PhD, Michael Laffan
Journal: Blood
Blood (2011) 118 (21): 2213.
https://doi.org/10.1182/blood.V118.21.2213.2213
Published: 2011
Journal Articles

Characterisation of W1745C and S1783A, Two Novel Collagen Binding Defects in the A3 Domain of Von Willebrand Factor

Anne Riddell, Keith Gomez, Carolyn Millar, G. Mellars, Simon A Brown, Saher Gill, Michael Laffan, Thomas A J McKinnon
Journal: Blood
Blood (2008) 112 (11): 424.
https://doi.org/10.1182/blood.V112.11.424.424
Published: 2008